Bender MedSystems Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Bender MedSystems General Information

Description

Manufacturer of reagents for immunological research and research diagnostics. The company provides the biomedical market with immunological research reagents and research diagnostics comprising monoclonal antibodies, enzyme-immunoassays (ELISA), fluorescent bead immunoassays, FlowCytomix and the proprietary technology Instant ELISA as well as recombinant proteins for applications in academic, industrial and clinical research in the fields of adhesion molecules, cytokines and receptors, tumour biology and apoptosis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Acquirer
Primary Office
  • Campus Vienna Biocenter 2
  • Vienna, 1030
  • Austria
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bender MedSystems Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bender MedSystems‘s full profile, request access.

Request a free trial